Consequently, in vivo elimination of CAFs in a murine model of breast cancer using a vaccine targeting FAP can shift CD4+ T cell polarization from a Th2 to a Th1, increase expression of IL-2, increase CD8+ T cell functions, and hamper Tregs recruitment [161]. The gene discussed is FAP; the disease is breast cancer.